Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review.

Journal: Cureus

Publication date: 

Journal: Cureus

Publication Year: 

Authors & Co-authors:  Kumari Chaudhry Sagot Doumas Abdullah Alcera Solhkhah Afzal